The discovery of these two genes being linked to breast and ovarian cancers has led to the increased importance of genetic testing where continuous research and development had ultimately resulted in BRCA1 and BRCA2 genetic tests being available at a more affordable cost and with a higher sensitivity and specificity [22]. This evidence concerns the gene BRCA1 and ovarian cancer.